COAGULATION FACTOR VIIA RECOMBINANT HUMAN for Off label use: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 26 adverse event reports in the FDA FAERS database where COAGULATION FACTOR VIIA RECOMBINANT HUMAN was used for Off label use.
Most Reported Side Effects for COAGULATION FACTOR VIIA RECOMBINANT HUMAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 169 | 17.8% | 85 | 50 |
| Haemorrhage | 129 | 13.6% | 21 | 53 |
| Drug ineffective | 117 | 12.3% | 26 | 47 |
| Death | 85 | 8.9% | 85 | 8 |
| Pre-existing disease | 78 | 8.2% | 78 | 22 |
| Therapy partial responder | 78 | 8.2% | 76 | 23 |
| Acquired haemophilia | 72 | 7.6% | 70 | 23 |
| Haemarthrosis | 47 | 4.9% | 3 | 27 |
| Haematoma | 30 | 3.2% | 3 | 21 |
| Therapy responder | 30 | 3.2% | 27 | 22 |
| Thrombosis | 27 | 2.8% | 6 | 12 |
| Condition aggravated | 23 | 2.4% | 8 | 11 |
| Shock haemorrhagic | 20 | 2.1% | 14 | 8 |
| Epistaxis | 19 | 2.0% | 0 | 13 |
| Haemorrhage intracranial | 19 | 2.0% | 7 | 8 |
Other Indications for COAGULATION FACTOR VIIA RECOMBINANT HUMAN
Acquired haemophilia (244)
Factor viii deficiency (130)
Product used for unknown indication (97)
Haemorrhage (92)
Prophylaxis (54)
Factor vii deficiency (51)
Haemophilia (44)
Haemophilia a with anti factor viii (43)
Factor ix deficiency (36)
Haemostasis (30)
Other Drugs Used for Off label use
LENALIDOMIDE (5,767)
ECULIZUMAB (3,550)
CERTOLIZUMAB PEGOL (2,256)
ABOBOTULINUMTOXINA (2,170)
LEVETIRACETAM (2,161)
APREMILAST (1,995)
PROPRANOLOL (1,576)
CETIRIZINE (1,416)
HUMAN IMMUNOGLOBULIN G (1,129)
THALIDOMIDE (1,033)